These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Persistent or new symptoms 1 year after a single high dose of vitamin D Fernandes AL; Sales LP; Santos MD; Caparbo VF; Murai IH; Pereira RMR Front Nutr; 2022; 9():979667. PubMed ID: 36176639 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic high-dose vitamin D for vitamin D-deficient severe COVID-19 disease: randomized, double-blind, placebo-controlled study (SHADE-S). Singh A; Rastogi A; Puri GD; Ganesh V; Naik NB; Kajal K; Kahlon S; Soni SL; Kaloria N; Saini K; Hazarika A; Mahajan V; Singla K; Bhadada S; Soni V J Public Health (Oxf); 2024 May; 46(2):256-266. PubMed ID: 38291897 [TBL] [Abstract][Full Text] [Related]
7. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial. Sabico S; Enani MA; Sheshah E; Aljohani NJ; Aldisi DA; Alotaibi NH; Alshingetti N; Alomar SY; Alnaami AM; Amer OE; Hussain SD; Al-Daghri NM Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202578 [TBL] [Abstract][Full Text] [Related]
8. Effect of a Single High-Dose Vitamin D3 on the Length of Hospital Stay of Severely 25-Hydroxyvitamin D-Deficient Patients with COVID-19. Murai IH; Fernandes AL; Antonangelo L; Gualano B; Pereira RMR Clinics (Sao Paulo); 2021; 76():e3549. PubMed ID: 34852148 [TBL] [Abstract][Full Text] [Related]
9. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial. Mariani J; Antonietti L; Tajer C; Ferder L; Inserra F; Sanchez Cunto M; Brosio D; Ross F; Zylberman M; López DE; Luna Hisano C; Maristany Batisda S; Pace G; Salvatore A; Hogrefe JF; Turela M; Gaido A; Rodera B; Banega E; Iglesias ME; Rzepeski M; Gomez Portillo JM; Bertelli M; Vilela A; Heffner L; Annetta VL; Moracho L; Carmona M; Melito G; Martínez MJ; Luna G; Vensentini N; Manucha W PLoS One; 2022; 17(5):e0267918. PubMed ID: 35622854 [TBL] [Abstract][Full Text] [Related]
10. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946 [TBL] [Abstract][Full Text] [Related]
11. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial. Annweiler C; Beaudenon M; Gautier J; Gonsard J; Boucher S; Chapelet G; Darsonval A; Fougère B; Guérin O; Houvet M; Ménager P; Roubaud-Baudron C; Tchalla A; Souberbielle JC; Riou J; Parot-Schinkel E; Célarier T; PLoS Med; 2022 May; 19(5):e1003999. PubMed ID: 35639792 [TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377 [TBL] [Abstract][Full Text] [Related]
15. Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela. Bahgat MM; Nadeem R; Nasraa MH; Amer K; Hassan WA; ELGarhy FM; Reda S; Abd-Elshafy DN Viral Immunol; 2023 Nov; 36(9):600-609. PubMed ID: 37831918 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
17. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract. Engelbrecht C; Sardinha LR; Rizzo LV Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443 [TBL] [Abstract][Full Text] [Related]
18. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. Amrein K; Schnedl C; Holl A; Riedl R; Christopher KB; Pachler C; Urbanic Purkart T; Waltensdorfer A; Münch A; Warnkross H; Stojakovic T; Bisping E; Toller W; Smolle KH; Berghold A; Pieber TR; Dobnig H JAMA; 2014 Oct; 312(15):1520-30. PubMed ID: 25268295 [TBL] [Abstract][Full Text] [Related]
19. High-dose vitamin D Smith EM; Alvarez JA; Kearns MD; Hao L; Sloan JH; Konrad RJ; Ziegler TR; Zughaier SM; Tangpricha V Clin Nutr; 2017 Aug; 36(4):980-985. PubMed ID: 27402475 [TBL] [Abstract][Full Text] [Related]
20. High-dose vitamin D3 in the treatment of severe acute malnutrition: a multicenter double-blind randomized controlled trial. Saleem J; Zakar R; Zakar MZ; Belay M; Rowe M; Timms PM; Scragg R; Martineau AR Am J Clin Nutr; 2018 May; 107(5):725-733. PubMed ID: 29722846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]